Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7101 - 7125 of 9783 in total

FR236913

Experimental

Inhibitor Idd 384

Experimental

LY-2608204

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Investigational

4SC-202

4SC-202 has been used in trials studying the treatment of Advanced Hematologic Malignancies.
Investigational

Succinylsulfathiazole

Experimental

5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one

Experimental

(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE

Experimental

(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide

Experimental

Cysteinamide

Experimental

N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE

Experimental

N-Acetyl-Serine

Experimental

Oseltamivir acid

Experimental

XV638

Experimental

FR-234938

Experimental

5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid

Experimental

Gallichrome

Experimental

7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane

Experimental

INHIBITOR Q8467 OF DUPONT MERCK

Experimental

Sofalcone

Sofalcone is a mucosal protective agent that has been reported to inhibit growth of Helicobacter pylori. on adherence, production of vacuolating toxin (VT), and induction of interleukin-8 (IL-8) secretion by H. pylori.
Investigational

[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid

Experimental

2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE

Experimental

2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid

Metabolic product of biphenyl; from Pseudomonas putida.
Experimental

(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid

Experimental

2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID

Experimental

Amedalin

Amedalin is a selective norepinephrine reuptake inhibitor developed in the 1970s. It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug was never marketed.
Experimental
Displaying drugs 7101 - 7125 of 9783 in total